Former Hedge Fund Manager Self-Fulfills Prison Prophecy (Deal Breaker)
This week has been filled with dark allegations and recriminations against hedge funds over conspiracies to nefariously game markets to their own ends, without any evidence to support them. So you may have missed the final chapter in the actual conspiracy to game a market by a nefarious hedge fund manager, one Dan Kamensky of Marble Ridge Capital.
Hedge-Fund Billionaire Ray Dalio Fears the GameStop Frenzy was Really about Wealth Inequality (Business Insider)
Billionaire investor Ray Dalio isn’t worried about the Reddit users who collectively drove GameStop’s stock price to stratospheric levels last week, or the short-selling hedge funds that were squeezed as a result. His real fear is that the GameStop saga was a symptom of broader inequality and division in America, he said on the Axios Re:Cap podcast this week. He pointed out gaps in wealth, values, and political views in the US are at their widest in more than 120 years.
COVID Nightmares for Women in Hedge Funds (eFinancialCareers.com)
Working in an investment role for a hedge fund during a time of family strife is a challenge irrespective of your gender. – In 2013, Paul Tudor Jones controversially claimed that hedge fund managers’ returns fall by 10-20% when they’re going through a divorce because they lose focus during the “emotional strife.” Now it seems that the COVID-19 pandemic has had a similar effect – but only for portfolio managers who are mothers.
Friday 2/5 Insider Buying Report: BSTZ, CFR (Nasdaq.com)
At Blackrock Science and Technology Trust II, a filing with the SEC revealed that on Tuesday, Tony Kim bought 13,200 shares of BSTZ, at a cost of $37.55 each, for a total investment of $495,694. So far Kim is in the green, up about 4.9% on their buy based on today’s trading high of $39.40. Blackrock Science and Technology Trust II is trading up about 0.5% on the day Friday. Before this latest buy, Kim bought BSTZ on 3 other occasions during the past year, for a total cost of $592,667 at an average of $15.05 per share. And at Cullen/Frost Bankers, there was insider buying on Wednesday, by Director Chris Avery who bought 3,500 shares for a cost of $92.71 each, for a total investment of $324,485. Before this latest buy, Avery bought CFR at 3 other times during the past year, for a total cost of $1.43M at an average of $86.64 per share. Cullen/Frost Bankers is trading up about 0.5% on the day Friday. So far Avery is in the green, up about 5.4% on their buy based on today’s trading high of $97.67.
The CFO & SVP of 1-800 Flowers (NASDAQ: FLWS) is Selling Shares (Analyst Ratings)
Yesterday, the CFO & SVP of 1-800 Flowers (FLWS), William E. Shea, sold shares of FLWS for $1.52M. Following William E. Shea’s last FLWS Sell transaction on June 13, 2018, the stock climbed by 17.5%. In addition to William E. Shea, one other FLWS executive reported Sell trades in the last month. Based on 1-800 Flowers’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $877 million and quarterly net profit of $114 million.
Teladoc Health Inc (TDOC) CEO Jason N Gorevic Sold $8.1 million of Shares (Guru Focus)
CEO of Teladoc Health Inc, Jason N Gorevic, sold 30,000 shares of TDOC on 02/02/2021 at an average price of $271.06 a share. The total sale was $8.1 million. Teladoc Inc provides telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone. Teladoc Health Inc has a market cap of $40.73 billion; its shares were traded at around $280.975000 with and P/S ratio of 25.02. Teladoc Health Inc had annual average EBITDA growth of 12.20% over the past five years. GuruFocus has detected 3 severe warning signs with Teladoc Health Inc.
